Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

N4 Pharma Shares Soar As Cancer Drug Moves To Phase Two Of Programme

Thu, 03rd Dec 2020 10:40

(Alliance News) - N4 Pharma PLC on Thursday announced that cancer drug Nuvec can be freeze dried and stored for 14 day without a significant drop in performance.

N4 Pharma shares were up 56% at 9.37 pence each in London on Thursday morning.

N4 Pharma is a Chellaston, England-based pharmaceutical company focused on the development of Nuvec, a novel delivery system for cancer treatments and vaccines.

N4 Pharma said Nuvec formulations which had been freeze dried and then stored for 14 days, either at room temperature or at four degrees celsius, showed no significant drop in in vitro transfection capability following its reconstitution.

Chief Executive Nigel Theobald said: "Demonstrating that Nuvec loaded with a plasmid DNA can be dried, stored at convenient temperatures and reconstituted without any drop in transfection is a significant step forward in our formulation development work."

Going forward, different formulations will be chosen for phase two of the work programme which will test the efficacy of the dried and reconstituted plasmid DNA in an in vivo antibody generation model.

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
7 Jun 2024 12:32

N4 Pharma raises GBP630,000 to advance primary work streams

(Alliance News) - N4 Pharma PLC on Friday said it has raised GBP630,000 through a placing and subscription of shares.

7 Jun 2024 11:06

N4 Pharma shares tank after £0.6m fundraise

(Sharecast News) - Shares in small-cap pharma group N4 Pharma sank on Friday after the company announced a share placing and subscription to raise ...

16 May 2024 15:46

UK shareholder meetings calendar - next 7 days

25 Apr 2024 11:56

N4 Pharma strikes partnership deal for intracellular delivery

(Alliance News) - N4 Pharma PLC on Thursday said it has entered into a collaboration agreement with SRI International Inc.

23 Apr 2024 13:32

IN BRIEF: N4 Pharma loss widens but "great optimism" remains

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company focused on the development of Nuvec - Posts revenue of GBP1,953 in 2023, compared to ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.